Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
PEGA Pegasystems Inc delivers narrow Q4 2025 earnings beat with shares rising modestly in regular trading Innventure INV Stock Hot on Social Media Drifts Lower 20260418 LZ LegalZoomcom Inc shares climb on doubledigit yearoveryear revenue growth despite minor EPS miss Illumina Inc ILMN Launches DRAGEN v45 Software to Expand Genomic Analysis Capabilities Across HighGrowth Segments MongoDB MDB Stock Overvalued 204 20260422 The biggest catalyst for Meridian Holdings MRDN nobody is watching Risk Aversion 20260511 AWK Amer Water shares climb 276 after Q4 2025 results post 97 YoY revenue growth despite modest EPS miss US Auto Industry Detroit Automakers Slash Over 20000 Salaried Positions Amid AI Adoption Minerva Neurosciences NERV Q1 2026 Earnings Miss Sparks Concern Local LOCL Delivers Q1 2026 Beat EPS 053 vs 054 Expected Leapfrog LFACU Steady at 1006 Awaiting Next Catalyst 20260518 Kevin Warsh Secures Senate Confirmation as Next Federal Reserve Chair in Historic Vote Roadzen RDZN Steady at 172 Awaiting Next Catalyst 20260519 Summer Gas Price Volatility Looming Experts Warn of Most Volatile Summer in Years NYTs Pips Puzzle Walkthrough Highlights Growing Role of Games in Subscription Strategy Inflation Projected to Reach 6 in Second Quarter Leading Forecasters Warn Analysts Offer Mixed Views on News Corporation Stock Amid Digital Transformation HALO Stocks Emerge as AIResistant Investment Theme New ETF Launches to Capitalize Chinas Commerce Minister Skips APEC Opening on Urgent Official Business Trade Representative Calls for Cooperation Castle Biosciences Q1 2026 Earnings NarrowerThanExpected Loss Stock Slips Draganfly DPRO Q1 2026 Earnings Narrow EPS Miss as Stock Rises But Revenue Remains Elusive VYX Q1 2026 Earnings EPS Surpasses Estimates by 212 Shares Edge Higher MGYR Q4 2025 Earnings EPS of 040 Reported Stock Unchanged Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress HHS Q2 2025 Earnings Narrower Loss and Modest Stock Gain Amid Sparse Disclosures Cinemark Holdings CNK Posts Modest Gain as Stock Approaches Key Resistance XOMAP Holds Steady at 2543 as Preferred Stock Maintains Parity Able View Global Warrant ABLVW Slides to 002 Amid Thin Trading AFGC Inches Up as Subordinated Debt Finds Steady Footing DLocal DLO Edges Higher as Investors Eye Key Resistance Level